KRAS and familial pancreatic carcinoma: In summary, NRF2 inhibits the transcription of NOS2. The interplay between KRAS G12D, NRF2 and NOS2 in the control of oxidative and nitrosative homeostasis in pancreatic cancer cells is summarised in Figure 5F.